Bristol-Myers Squibb Company (BMY) Q2 2024 Earnings Results

Bristol-Myers Squibb Beats on EPS, Stock Up 11.44%

Bristol-Myers Squibb reported a strong earnings per share, exceeding expectations significantly. The stock reacted positively, rising by 11.44%, likely driven by investor confidence in the company's performance despite the lack of revenue data and management commentary.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.07	N/A	+26.53%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Bristol-Myers Squibb Beats on EPS, Stock Up 11.44%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol-Myers Squibb Beats on EPS, Stock Up 11.44%

Key numbers

Management commentary